Zealand Pharma makes stalking horse bid for Valeritas
Danish biotechnology firm, Zealand Pharma has made a bid to acquire Valeritas, a medical technology...
Read More...
Focus:
Denmark
-
ADvirtual
ADvirtual creates customised simulations for training critical operations and procedures for life science and healthcare...
Read More...
-
![Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn]()
Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Japan-based Asahi Kasei, through its subsidiary Asahi Kasei Pharma Denmark, has offered to acquire Veloxis...
Read More...
-
Novo Ventures and Broad Institute sign drug discovery deal
Novo Ventures, a part of Danish investment group Novo Holdings, has collaborated with Broad Institute...
Read More...
-
![Novo Nordisk and Dicerna to develop new RNAi drugs]()
Novo Nordisk and Dicerna to develop new RNAi drugs
Novo Nordisk has partnered with Dicerna Pharmaceuticals for the discovery and development of new RNAi...
Read More...
-
Zealand Pharma to acquire Canada’s Encycle Therapeutics
Danish biotechnology firm Zealand Pharma has agreed to buy all outstanding shares and intellectual property...
Read More...
-
![Bavarian Nordic to acquire two travel vaccines from GSK]()
Bavarian Nordic to acquire travel vaccines from GSK
Danish biotechnology firm Bavarian Nordic has signed an agreement to buy two commercial travel vaccines,...
Read More...
-
![Novo Nordisk and bluebird bio focus on genetic disease therapies]()
Novo Nordisk and bluebird bio to develop genetic disease therapies
Danish healthcare company Novo Nordisk has allied with US-based gene therapies firm bluebird bio to...
Read More...
-
![Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals]()
Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals
Danish pharmaceutical company Lundbeck has signed a definitive agreement to acquire all outstanding shares of...
Read More...
-
Genmab partners Tempus to identify new cancer targets
Danish biotechnology company Genmab has partnered with US-based technology firm Tempus to research and develop...
Read More...
Close
Close
Close
Go Top